Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Losartan potassium 50 mg oral tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
pantoprazol 40 mg enterotablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
venlafaxin 37,5 mg tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Fenbufen 450 mg oral tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Thioridazine hydrochloride 200 mg oral tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Morphine sulfate 50 mg oral tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Tetracycline 500 mg oral tablet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Agalsidase beta 5 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Cefradine 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Cefradine 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cefradine 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Amphotericin B 50 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amphotericin B 50 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dantrolene sodium 20 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dantrolene sodium 20 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
cyclophosphamid 2 g/pulver til injektionsvæske, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
cyclophosphamid 2 g/pulver til injektionsvæske, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alprostadil 20 microgram powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alprostadil 40 microgram powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alprostadil 40 microgram powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
doripenem 500 mg, pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
doripenem 500 mg, pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alprostadil 5 microgram powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alprostadil 5 microgram powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Alteplase 10 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Alteplase 10 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aztreonam 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aztreonam 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Aztreonam 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Aztreonam 2 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aztreonam 2 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amobarbital sodium 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amobarbital sodium 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Basiliximab 10 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Basiliximab 10 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Basiliximab 20 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Basiliximab 20 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Diamorphine hydrochloride 10 mg powder for solution for injection ampule |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |